Clinical Trial Update: A Trial of HRS8179 on Brain Swelling After Large Hemispheric Infarction [Phase 2]

View source ↗

Summary

Phase 2 trial of HRS8179 for brain swelling after large hemispheric infarction has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Large Hemispheric Infarction
• Stroke

Drugs mentioned

• HRS8179

Snippet

Sponsor: Beijing Suncadia Pharmaceuticals Co., Ltd | Conditions: Brain Swelling, Large Hemispheric Infarction | Phase 2 | Status: COMPLETED